Zoledronic acid sensitizes tumor cells to radiation: in response to Algur et al. (Int J Radiat Oncol Biol Phys 2005;61:535-542).
Ural
A Ugur
AU
Avcu
Ferit
F
D000818:Animals; D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D003131:Combined Modality Therapy; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy / Q000532:radiotherapy; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D016283:Proto-Oncogene Proteins p21(ras) / Q000378:metabolism; D011836:Radiation Tolerance; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D011838:Radiation-Sensitizing Agents; D000077211:Zoledronic Acid; D016283:Proto-Oncogene Proteins p21(ras)